Country Head for Türkiye | Cromos Pharma
Cromos Pharma’s new Country Head for Türkiye Cromos Pharma is delighted to introduce Seniz Sagol as our new Country Head for Türkiye. Seniz Sagol Tuysuz brings over 22 years of expertise in Clinical Operations, with a comprehensive background in Global Project Management, Country Management, and Line Management across diverse functions. A pharmacist by education, Seniz has held pivotal roles such as Head
Happy Thanksgiving Day 2023 | Cromos Pharma
Happy Thanksgiving Day 2023 On this Thanksgiving day, Cromos Pharma extends heartfelt gratitude to our valued staff, partners, clients, and friends. “Gratitude is not only the greatest of virtues but the parent of all others.” – Marcus Tullius Cicero. May your day be filled not only with warmth but also with the joy that stems from a profound sense
New Weight Loss Drug Zepbound Receives FDA Approval | Cromos Pharma
New Weight Loss Drug Zepbound Receives FDA Approval Amid Calls for Comprehensive Coverage of Obesity Treatments The U.S. Food and Drug Administration (FDA) has granted approval to Zepbound (tirzepatide) injection for chronic weight management in adults with obesity or overweight and at least one weight-related condition. This approval addresses a critical medical need as obesity affects about 70% of American adults. Zepbound, the active ingredient in Mounjaro, is administered weekly through

Schedule a meeting

We are excited to connect with you, understand your goals, and explore how we can support your needs.

Contact us